In contrast, a meta-analysis found that mVSS was more favourable in the NXB group than in the standard care group, although this difference did not reach statistical significance [ 26 ].
← all excerpts
Japanese Consensus Document on NexoBrid<sup>®</sup>, a Burn Eschar Removal Agent.
1
—
—